Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.

Oncotarget - 22 Nov 2016

Yao Kun, Duan Zejun, Zhou Jian, Li Lin, Zhai Feng, Dong Yanting, Wang Xiaoyan, Ma Zhong, Bian Yu, Qi Xueling, Li Liang

Abstract excerpt

Focal cortical dysplasia (FCD) II and I are major causes for drug-resistant epilepsy. In order to gain insight into the possible correlations between FCD II and FCD I, different clinical characteristics and immunohistochemical expression characteristics in FCD I and II were analyzed. The median age of onset and duration of epilepsy in FCD I and FCD II patients were 2.1 years and 5.3 years vs 2.4 years and 4.5...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Cerebral Cortex
Share to Epilepsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorescent Antibody Technique

Share to Kruppel-Like Factor 4

Share to Malformations of Cortical Development

Share to Symptom Assessment

Share to White Matter

Source

Open in PubMed Open full text

Identifiers

PMID: 27811355
DOI: 10.18632/oncotarget.13001
PMCID: PMC5363519

Genes

KLF4
SOX2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.PMID 27811355Read ↗

Focal cortical dysplasia type II: review of neuropathological manifestations and pathogenetic mechanismsSemantic proximity Read ↗

Toward a refined genotype-phenotype classification scheme for the international consensus classification of Focal Cortical Dysplasia.Semantic proximity Read ↗

Focal cortical dysplasia: a practical guide for neurologists.Semantic proximity Read ↗

Genomic and Epigenetic Advances in Focal Cortical Dysplasia Types I and II: A Scoping ReviewSemantic proximity Read ↗

Updates from the International League Against Epilepsy Classification of Epilepsy (2017) and Focal Cortical Dysplasias (2022): Imaging Phenotype and Genetic Characterization.Semantic proximity Read ↗

Deep histopathology genotype-phenotype analysis of focal cortical dysplasia type II differentiates between the GATOR1-altered autophagocytic subtype IIa and MTOR-altered migration deficient subtype IIb.Semantic proximity Read ↗

[Advances of pathological research and classification in malformations of cortical development associated with refractory epilepsy].Semantic proximity Read ↗

Identifying cellular markers of focal cortical dysplasia type II with cell-type deconvolution and single-cell signaturesSemantic proximity Read ↗

Somatic Mosaicism Patterns Define Clinical-Surgical Subtypes of Focal Cortical Dysplasia Through Cell-Type-Specific ExpressionSemantic proximity Read ↗

Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.Semantic proximity Read ↗

Identifying cellular markers of focal cortical dysplasia type II with cell-type deconvolution and single-cell signaturesSemantic proximity Read ↗

Focal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.